Literature DB >> 28825856

The Use of Variant Maps to Explore Domain-Specific Mutations of FGFR1.

L A Lansdon1,2,3, H V Bernabe4, N Nidey1, J Standley1, M J Schnieders4, J C Murray1,3.   

Abstract

Here we describe the genotype-phenotype correlations of diseases caused by variants in Fibroblast Growth Factor Receptor 1 ( FGFR1) and report a novel, de novo variant in FGFR1 in an individual with multiple congenital anomalies. The proband presented with bilateral cleft lip and palate, malformed auricles, and bilateral ectrodactyly of his hands and feet at birth. He was later diagnosed with diabetes insipidus, spastic quadriplegia, developmental delay, agenesis of the corpus callosum, and enlargement of the third cerebral ventricle. We noted the substantial phenotypic overlap with individuals with Hartsfield syndrome, the rare combination of holoprosencephaly and ectrodactyly. Sequencing of FGFR1 identified a previously unreported de novo variant in exon 11 (p.Gly487Cys), which we modeled to determine its predicted effect on the protein structure. Although it was not predicted to significantly alter protein folding stability, it is possible this variant leads to the formation of nonnative intra- or intermolecular disulfide bonds. We then mapped this and other disease-associated variants to a 3-dimensional model of FGFR1 to assess which protein domains harbored the highest number of pathogenic changes. We observed the greatest number of variants within the domains involved in FGF binding and FGFR activation. To further explore the contribution of each variant to disease, we recorded the phenotype resulting from each FGFR1 variant to generate a series of phenotype-specific protein maps and compared our results to benign variants appearing in control databases. It is our hope that the use of phenotypic maps such as these will further the understanding of genetic disease in general and diseases caused by variation in FGFR1 specifically.

Entities:  

Keywords:  Hartsfield syndrome; clinical phenotypes; craniofacial anomalies; craniofacial biology/genetics; genetics; protein modeling

Mesh:

Substances:

Year:  2017        PMID: 28825856      PMCID: PMC5613887          DOI: 10.1177/0022034517726496

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  35 in total

1.  Impaired FGF signaling contributes to cleft lip and palate.

Authors:  Bridget M Riley; M Adela Mansilla; Jinghong Ma; Sandra Daack-Hirsch; Brion S Maher; Lisa M Raffensperger; Erilynn T Russo; Alexandre R Vieira; Catherine Dodé; Moosa Mohammadi; Mary L Marazita; Jeffrey C Murray
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-06       Impact factor: 11.205

2.  Frequency of Impaired Fibroblast Growth Factor Receptor 1 Signaling as a Cause of Normosmic Idiopathic Hypogonadotropic Hypogonadism.

Authors:  Taneli Raivio; Yisrael Sidis; Lacey Plummer; Huaibin Chen; Jinghong Ma; Abir Mukherjee; Elka Jacobson-Dickman; Richard Quinton; Guy Van Vliet; Helene Lavoie; Virginia A Hughes; Andrew Dwyer; Frances J Hayes; Shuyun Xu; Susan Sparks; Ursula B Kaiser; Moosa Mohammadi; Nelly Pitteloud
Journal:  Endocr Rev       Date:  2009-12-01       Impact factor: 19.871

3.  Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome.

Authors:  Catherine Dodé; Jacqueline Levilliers; Jean-Michel Dupont; Anne De Paepe; Nathalie Le Dû; Nadia Soussi-Yanicostas; Roney S Coimbra; Sedigheh Delmaghani; Sylvie Compain-Nouaille; Françoise Baverel; Christophe Pêcheux; Dominique Le Tessier; Corinne Cruaud; Marc Delpech; Frank Speleman; Stefan Vermeulen; Andrea Amalfitano; Yvan Bachelot; Philippe Bouchard; Sylvie Cabrol; Jean-Claude Carel; Henriette Delemarre-van de Waal; Barbara Goulet-Salmon; Marie-Laure Kottler; Odile Richard; Franco Sanchez-Franco; Robert Saura; Jacques Young; Christine Petit; Jean-Pierre Hardelin
Journal:  Nat Genet       Date:  2003-03-10       Impact factor: 38.330

4.  An unusual FGFR1 mutation (fibroblast growth factor receptor 1 mutation) in a girl with non-syndromic trigonocephaly.

Authors:  W Kress; B Petersen; H Collmann; T Grimm
Journal:  Cytogenet Cell Genet       Date:  2000

5.  Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism.

Authors:  Nelly Pitteloud; Richard Quinton; Simon Pearce; Taneli Raivio; James Acierno; Andrew Dwyer; Lacey Plummer; Virginia Hughes; Stephanie Seminara; Yu-Zhu Cheng; Wei-Ping Li; Gavin Maccoll; Anna V Eliseenkova; Shaun K Olsen; Omar A Ibrahimi; Frances J Hayes; Paul Boepple; Janet E Hall; Pierre Bouloux; Moosa Mohammadi; William Crowley
Journal:  J Clin Invest       Date:  2007-01-18       Impact factor: 14.808

6.  Responsiveness to a physiological regimen of GnRH therapy and relation to genotype in women with isolated hypogonadotropic hypogonadism.

Authors:  Brent S Abel; Natalie D Shaw; Jenifer M Brown; Judith M Adams; Teresa Alati; Kathryn A Martin; Nelly Pitteloud; Stephanie B Seminara; Lacey Plummer; Duarte Pignatelli; William F Crowley; Corrine K Welt; Janet E Hall
Journal:  J Clin Endocrinol Metab       Date:  2013-01-22       Impact factor: 5.958

7.  Mutational Spectrum in Holoprosencephaly Shows That FGF is a New Major Signaling Pathway.

Authors:  Christèle Dubourg; Wilfrid Carré; Houda Hamdi-Rozé; Charlotte Mouden; Joëlle Roume; Benmansour Abdelmajid; Daniel Amram; Clarisse Baumann; Nicolas Chassaing; Christine Coubes; Laurence Faivre-Olivier; Emmanuelle Ginglinger; Marie Gonzales; Annie Levy-Mozziconacci; Sally-Ann Lynch; Sophie Naudion; Laurent Pasquier; Amélie Poidvin; Fabienne Prieur; Pierre Sarda; Annick Toutain; Valérie Dupé; Linda Akloul; Sylvie Odent; Marie de Tayrac; Véronique David
Journal:  Hum Mutat       Date:  2016-08-23       Impact factor: 4.878

8.  Spectrum of phenotype and genotype of congenital isolated hypogonadotropic hypogonadism in Asian Indians.

Authors:  Sandhya Nair; Swati Jadhav; Anurag Lila; Varsha Jagtap; Amol Bukan; Reshma Pandit; Alka Ekbote; Mala Dharmalingam; Prasanna Kumar; Pramila Kalra; Pramod Gandhi; Rama Walia; Shilpa Sankhe; Vijaya Raghavan; Vyankatesh Shivane; Padma Menon; Tushar Bandgar; Nalini Shah
Journal:  Clin Endocrinol (Oxf)       Date:  2016-02-12       Impact factor: 3.478

9.  Search for genetic modifiers of IRF6 and genotype-phenotype correlations in Van der Woude and popliteal pterygium syndromes.

Authors:  Elizabeth J Leslie; Jennifer L Mancuso; Brian C Schutte; Margaret E Cooper; Kate M Durda; Jamie L'Heureux; Theresa M Zucchero; Mary L Marazita; Jeffrey C Murray
Journal:  Am J Med Genet A       Date:  2013-08-15       Impact factor: 2.802

10.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

View more
  1 in total

1.  A novel dominant-negative FGFR1 variant causes Hartsfield syndrome by deregulating RAS/ERK1/2 pathway.

Authors:  Pietro Palumbo; Antonio Petracca; Roberto Maggi; Tommaso Biagini; Grazia Nardella; Michele Carmine Sacco; Elia Di Schiavi; Massimo Carella; Lucia Micale; Marco Castori
Journal:  Eur J Hum Genet       Date:  2019-02-20       Impact factor: 4.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.